DXCM — DEXCOM INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1093557 ·
Last close
$71.54
Market Cap
$27.61B
52W High
$79.15
52W Low
$56.72
ADV30
4,665,382
Next earnings
2026-07-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,191,900,000 | 750,300,000 | 255,300,000 | 199,500,000 | 6,633,300,000 | 1,118,200,000 | 3,676,400,000 |
| Dec 2025 | 1,259,600,000 | 792,700,000 | 323,000,000 | 267,300,000 | 6,339,900,000 | 917,700,000 | 3,593,900,000 |
| Sep 2025 | 1,209,300,000 | 731,400,000 | 242,500,000 | 283,800,000 | 7,500,000,000 | 1,835,700,000 | 4,773,900,000 |
| Jun 2025 | 1,157,100,000 | 688,800,000 | 212,600,000 | 179,800,000 | 7,327,000,000 | 1,159,000,000 | 4,753,900,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,782,500,000
Investing CF
$137,300,000
Financing CF
$-1,723,900,000
CapEx
$-353,100,000
Dividends Paid
—
Buybacks
$-1,062,800,000
EPS Diluted TTM
$2.34
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$2,633,400,000
Inventory
$693,600,000
Receivables
$1,105,200,000
ST Investments
$1,297,000,000
EBIT TTM
$1,220,300,000
Pretax Income TTM
$1,203,600,000
Interest Exp TTM
$16,700,000
Analysts
24
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,817,900,032
EBITDA
$1,292,300,032
Free Cash Flow
$1,056,637,504
Enterprise Value
$26,165,927,936
Total Cash
$2,415,200,000
Total Debt
$1,384,800,000
Shares Out
385,872,977
Trailing EPS
$2.33
Book Value
$7.66
ROE
35.6%
ROA
9.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,662,000,000 | 911,800,000 | 836,300,000 | 6,339,900,000 | 3,593,900,000 | — | 1,440,700,000 |
| Dec 2024 | 4,033,000,000 | 600,000,000 | 576,200,000 | 6,484,500,000 | 4,381,900,000 | — | 989,500,000 |
| Dec 2023 | 3,622,300,000 | 597,700,000 | 541,500,000 | 6,264,500,000 | 4,195,900,000 | — | 748,500,000 |
| Dec 2022 | 2,909,800,000 | 391,200,000 | 341,200,000 | 5,391,700,000 | 3,259,900,000 | — | 669,500,000 |
TTM Snapshot
Revenues TTM
$3,389,000,000
NetIncome TTM
$443,800,000
OpCashFlow TTM
$0
Assets (Latest)
$6,484,500,000
Forward EPS
$3.08
Max Pain — expiry 2026-08-21
max pain strike: $70.00 · spot: $71.54 · call oi: 6,328 · put oi: 4,158
Expected Move to 2026-08-21:
±$8.25
(11.53%) —
implied range
$63.29 –
$79.79
· ATM straddle on $71.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GEHC | GE HealthCare Technologies Inc. | $27.56B | $60.58 | — |
| FSNUY | Fresenius SE & Co. KGaA | $28.12B | $12.48 | — |
| RYLPF | KONINKLIJKE PHILIPS NV | $27.06B | $27.84 | — |
| RMD | RESMED INC | $28.33B | $195.27 | — |
| PHG | KONINKLIJKE PHILIPS NV | $25.44B | $26.17 | — |
News headlines (Yahoo Finance, 1h cache)
DexCom (DXCM) Earnings Expected to Grow: Should You Buy?
2026-07-23 14:00 · Yahoo
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program
2026-07-22 21:15 · Yahoo
Are Medical Stocks Lagging DexCom (DXCM) This Year?
2026-07-21 13:40 · Yahoo
2 Cash-Heavy Stocks on Our Buy List and 1 We Avoid
2026-07-21 11:02 · Yahoo
What Investors Don’t Understand About Abbott Laboratories
2026-07-16 11:40 · Yahoo
DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM
2026-07-14 14:20 · Yahoo
1 Mid-Cap Stock to Target This Week and 2 We Find Risky
2026-07-14 11:03 · Yahoo
Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights
2026-07-14 04:30 · Yahoo
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes
2026-07-13 20:45 · Yahoo
Is DexCom (DXCM) Undervalued Following Its Investor Day Sentiment Shift?
2026-07-10 23:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.